CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

• How Pharmacometrics Informs Dose Selection And Biomarker Decisions

  Quantitative modeling informs dose selection and biomarker insights early, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.

• Anthropic's Stainless Acquisition: What It Means For Clinical Trials

  As AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.

• Don't Just Swap The Engine. Redesign The Factory.

  Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.

• What Is Ontology? Learn About The Data Layer That Makes Agentic AI Work

   Get an overview of ontology, the "semantic translator" that determines whether your AI investments actually compound or stay forever siloed.

• Early-Stage Biotech's AI Advantage Is A Window That Closes

  FDA AI guidance won’t build your strategy for you. Learn how biotech teams can avoid retrofits and design smarter clinical AI from day one.